jeudi 23 novembre 2017

Onco Actu du 23 novembre 2017

1. Biologie

New study points the way to therapy for rare cancer that targets the young [The Rockefeller University]

3.1 Prévention - Tabac

Expanding Smoking Cessation Services at NCI-designated Cancer Centers: An Interview with Dr. Glen Morgan [NCI]

3.8 Prévention - Alimentation

Three cups of coffee a day 'may have health benefits' [BBC News]

4. Dépistage, diagnostic et pronostic

Integrative prediction model uses “omics”, histopathology to improve cancer prognosis [Stanford Medicine]

5.12 Immunothérapies

How Does Lung Cancer Evade the Immune System? [Cancer Research Catalyst]

5.2.3 Pharma - économie

Roche and the City of Hope effort to block Pfizer biosimilar version of trastuzumab [Harvard Law Blog]

Under pressure from copycats, Roche sues Pfizer over Herceptin rival [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

New EudraVigilance system is live [EMA]

5.4 Traitements - Economie

Roche’s Erivedge no longer funded by the NHS [PharmaTimes]

Life-saving prostate cancer treatment denied on NHS for a year despite approval by safety watchdogs [The Telegraph]

6.1 Observation

Adult Survivors of Childhood Cancer Are More Likely to Develop High Blood Pressure [AACR]

Risk for Aging-related Diseases Elevated Among Thyroid Cancer Survivors [AACR]

6.6 Publications

US court issues injunction against OMICS to stop “deceptive practices” [Retraction Watch]

Editorial board of public health journal resigns in protest [Retraction Watch]